Eurofins Scientific

History

Year	Detail
1987	Eurofins was founded.
2000	IPO was listed followed by a secondary listing on Frankfurt Deutsche Börse.
2001	Market leading positions were built in core markets in several European countries as well as new areas of activity such as genomic services and contaminants testing.
2005	Global expansion including China, Sweden, Norway and Ireland.
2013	The Animal ID DNA Test by Eurofins got validated.
2014	Entered the specialty clinical diagnostics.
2018	Eurofins became the market leader in food and environment testing in North America.
2020	Eurofins laboratories developed a complete range of PCR tests to detect SARS-CoV-2 and serology tests to detect antibodies.
2021	Eurofins acquired DNA Diagnostics Center.
2022	Eurofins acquired majority stake in Ajal for Laboratories.
2023	Eurofins Viracor Launches Test for Assessing Expansion and Persistence of CAR-T Therapy in Cancer Patients.